Elan shares rise on settlement of dispute

Elan shares have risen dramatically, from $4.2 to $ 5.9 over the last week.

Elan shares rise on settlement of dispute

Elan shares have risen dramatically, from $4.2 to $ 5.9 over the last week.

Elan has settled its dispute with US pharmaceutical company King which has now agreed to pay around $750m (€634m) to Elan for the US rights to two of Elan's drugs.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited